Lotus Pharmaceutical Co., Ltd. (1795.TW) TAI

196.00

-2.5(-1.26%)

Updated at June 02 01:30PM

Currency In TWD

Lotus Pharmaceutical Co., Ltd.

Address

No. 277 Song Ren Road

Taipei, 110

Taiwan (Province of China)

Phone

886 2 2700 5908

Website

https://www.lotuspharm.com.tw

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

1099

First IPO Date

December 21, 2007

Key Executives

Name	Title	Pay	Year Born
Petar Antonov Vazharov	Chief Executive Officer & Director	52.91M	N/A
Eeling Chan	Chief Financial Officer	5.19M	N/A
Gwen Hsieh	Chief Information Officer	8.5M	N/A
Manish Chawla	Vice President of Research and Development	13.61M	N/A
Bjartur Shen	Vice President of Strategies & Finance	28.71M	N/A
Edin Buljubasic	Vice President of Legal and Compliance	0	N/A
Fiona Lei	Head of Human Resources	0	N/A
Vamsi Kiran Kosaraju	Chief Operations Officer	0	N/A
Yi Ling Tian	Accounting Supervisor	0	N/A
Jeffrey Tsang	Head of Investor Relations & Corporate Communications	0	N/A

Description

Lotus Pharmaceutical Co., Ltd. research, develops, manufactures, and sells generic pharmaceutical products in Taiwan, Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, cardiology, nephrology, women's health, anti-obesity, and central nervous system disease. The company also sells and markets a portfolio of over-the-counter medicines. In addition, it engages in wholesale of cosmetics; retail of clinical machines; biotech technological consulting services; sale of pharmaceuticals and medicinal chemical; marketing activities; market planning and business information services; and consultancy services on health management, health technology, and trading information services. Further, the company offers pharmaceutical regulatory affairs project management, and data collection and agency services; healthcare consultancy services and operates as a contract research organization. Lotus Pharmaceutical Co., Ltd. was incorporated in 1966 and is headquartered in Taipei City, Taiwan. Lotus Pharmaceutical Co., Ltd. is a subsidiary of Alvogen Emerging Markets Holdings Limited.